Arthritis Monoclonal Antibodies Market By Segmentation, By Region 2021 | Industry Volume, Value, Trends, Size, Share, Sales, and Key Players Revenue Analysis Report 2021-2026

Arthritis Monoclonal Antibodies Market Growth and Forecast (2021-2026):

Arthritis Monoclonal Antibodies Market is expected to decline from $46.48 billion in 2019 to $45.18 billion in 2020 at a compound annual growth rate (CAGR) of -2.8%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $56.05 billion in 2023 at a CAGR of 7.45%.

Arthritis Monoclonal Antibodies Market is Segmented by Drug into Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima, by Application into Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Others.

To know more about Market and Our Research Methodology Download Sample Brochure

Arthritis Monoclonal Antibodies Market Segmentation Analysis:

By Drug:

  • Remicade
  • Humira
  • Enbrel
  • Rituxan
  • Orencia
  • Actemra
  • Simponi
  • Cimzia
  • Remsima

By Application:

  • Rheumatoid Arthritis
  • Osteoarthritis
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Fibromyalgia
  • Others

Geographical Analysis:

North America

  • U.S
  • Canada
  • Mexico


  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe


  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico

Middle East and Arica

  • Middle-East
  • Africa

Key Players in the Market:

Major Key Players in the Global Arthritis Monoclonal Antibodies Market are

  • Johnson & Johnson
  • Roche
  • Novartis,
  • Pfizer Inc
  • AbbVie Inc
  • Amgen Inc
  • Genentech
  • GSK
  • AstraZeneca PLC
  • Mylan N.V
  • Bristol Myers Squibb
  • Eli Lily and Company

Please fill the form for Table of Content